Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.

@article{Jeong2015TumefactiveDL,
  title={Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.},
  author={In Hye Jeong and Su-Hyun Kim and J M Hyun and AeRan Joung and H Cho and Ho Jin Kim},
  journal={Journal of the neurological sciences},
  year={2015},
  volume={358 1-2},
  pages={118-24}
}
BACKGROUND Tumefactive demyelinating lesions (TDLs) are associated with a variety of demyelinating diseases in the central nervous system (CNS). However, there are no current guidelines describing how to classify and treat patients with this rare phenotype. Thus, the present study aimed to determine the long-term evolution and disease course of patients initially presenting with TDLs and to describe their clinical and radiographic characteristics. METHODS From the National Cancer Center… CONTINUE READING
Highly Cited
This paper has 30 citations. REVIEW CITATIONS